Sir,

Mutations in several genes have been identified in congenital abnormalities of kidneys and urinary tract (CAKUT): heterozygous mutations in *HNF1β* account for 8%, while other genes (*PAX2*, *EYA1, SALL1, SIX1*) have been identified as causing isolated renal hypo/dysplasia to a lesser extent in humans \[[@R1]\].

Despite extensive *HNF1β* molecular analysis, including direct sequencing of the minimal promoter and of the nine exons associated with screening for exonic rearrangement, *HNF1β* genetic testing failed to identify mutations in a majority of patients with CAKUT, even in individuals with very evocative renal phenotype \[[@R2]\]. Recently, specifically conserved *cis*-acting RARE (retinoic acid responsive element) and T-MARE (MafB responsive element) regulatory sequences have been identified \[[@R4]\]. RA signalling cascade and MafB bind RARE and T-MARE regulatory DNA sequences, respectively, and promote the expression of *Hnf1β* in both the caudal hindbrain (r4/r5 boundary) and pancreas. These sequences are both located in intron 4 of *HNF1β* and are not actually studied for the purpose of diagnosis. Finally, the roles of RA and MAFB in kidney development suggest that the RA-MAFB-HNF1*β* pathway may also be functional in human kidney.

In this study, we hypothesized that mutations in the highly conserved (see Figure [1](#F1){ref-type="fig"}) RARE and T-MARE regulatory sequences could disturb the early embryologic process of intermediate mesoderm, from which kidneys and urinary tract both derived, and consequently lead to renal phenotype mimicking *HNF1β*-related nephropathy.

![Alignment of human, mouse and chick nucleotide sequences from the enhancer of *HNF1β* (within intron 4): RARE and T-MARE regulatory sequences (boxes). Dashes indicate conserved residues.](sfp039fig1){#F1}

Among the 63 individuals we tested for *HNF1β*, a mutation was identified in 12 (19%). We therefore performed molecular analysis of these regulatory sequences in the 51 remaining patients with isolated or syndromic CAKUT of unknown origin for whom previous molecular analysis of *HNF1β* (QMPSF and direct sequencing) had failed to identify any causative mutation. All patients gave informed consent according to French law. Renal and extra-renal features of the 51 tested patients \[31 males, 20 females, median age 9 years (0--53)\] are summarized in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively. RARE and T-MARE regulatory sequences were amplified by PCR using a set of primers deduced from the genomic sequence (forward: TC CCCAGAACCCTCTTCCTA, reverse: TGGTTCAAAGC CCCAACTTA), corresponding to amplification of a 344 bp fragment (G1266--17138 to G1266--16794). Among the 51 tested patients, no sequence variation of the RARE and T-MARE regulatory sequences of *HNF1β* was evidenced.

###### 

Renal characteristics of 51 patients with CAKUT tested for RARE and T-MARE regulatory sequences of *HNF1β*

  Renal features               *N*   
  ---------------------------- ----- -----
  Hyperechogenicity            16    31%
  Renal cysts                  33    65%
  Kidney size                        
  Normal                       27    52%
  Enlarged                     4     8%
  Unilateral hypoplasia        8     16%
  Bilateral hypoplasia         12    24%
  Urinary tract malformation         
  Bilateral VUR                6     12%
  Solitary kidney              5     10%
  Ectopic kidney               3     6%
  UPJO                         1     2%
  Oligomeganephronia           1     2%
  Chronic renal failure        17    33%

CAKUT: congenital abnormalities of kidneys and urinary tract, VUR: vesico-ureteric reflux, UPJO: uretero-pyelic junction obstruction.

###### 

Extra-renal characteristics of 51 patients with CAKUT tested for RARE and T-MARE regulatory sequences of *HNF1β*

  Extra-renal features                    *N*   
  --------------------------------------- ----- ----
  Genital tract                                 
  Cryptorchidism                          2     4%
  Bicornual uterus                        1     2%
  MRKH syndrome                           1     2%
  Vas deferens absence                    2     4%
  Testis + semen vesicle hypoplasia       1     2%
  Liver                                         
  Abnormal liver tests                    1     2%
  Choledochal cyst and DM                 1     2%
  Pancreas                                      
  Chronic calcified pancreatitis and DM   2     4%
  Mental retardation                      1     2%
  Retinal oedema                          1     2%

MRKH: Mayer-Rokitansky-Küster-Hauser, DM: diabetes mellitus.

In conclusion, although mutations in RARE and T-MARE regulatory sequences of *HNF1β* may nevertheless be implicated in some renal congenital disorders, we show here that mutations in these sequences are not a frequent cause of CAKUT. More experiments are required to assess the role of the RA-MAFB-HNF1*β* pathway in kidney development. Moreover, the molecular basis of these renal malformations is still poorly understood, and further works remain to be done to identify new CAKUT genes. Delineation of transcriptional networks involved in early human metanephros development may be a way to identify these new genes.
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